ECSP16078100A - Nuevo uso de n,n -2-bis- mercaptoetil isoftalamida - Google Patents
Nuevo uso de n,n -2-bis- mercaptoetil isoftalamidaInfo
- Publication number
- ECSP16078100A ECSP16078100A ECIEPI201678100A ECPI201678100A ECSP16078100A EC SP16078100 A ECSP16078100 A EC SP16078100A EC IEPI201678100 A ECIEPI201678100 A EC IEPI201678100A EC PI201678100 A ECPI201678100 A EC PI201678100A EC SP16078100 A ECSP16078100 A EC SP16078100A
- Authority
- EC
- Ecuador
- Prior art keywords
- bis
- new use
- mercaptoethyl isophthalamide
- isophthalamide
- mercaptoethyl
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 229940072107 ascorbate Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- QZUPTXGVPYNUIT-UHFFFAOYSA-N isophthalamide Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1 QZUPTXGVPYNUIT-UHFFFAOYSA-N 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
De acuerdo con la invención, se proporciona N,N-bis-2-mercaptoetil isoftalamida, o una sal o derivado farmacéuticamente aceptable de la misma, para su uso en la regeneración de ascorbato sistémicamente y, por lo tanto, en el tratamiento terapéutico de la enfermedad pulmonar obstructiva crónica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406115.4A GB2524831A (en) | 2014-04-04 | 2014-04-04 | New pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP16078100A true ECSP16078100A (es) | 2018-03-31 |
Family
ID=50776843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201678100A ECSP16078100A (es) | 2014-04-04 | 2016-09-30 | Nuevo uso de n,n -2-bis- mercaptoetil isoftalamida |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US9782368B2 (es) |
| EP (1) | EP3125876B8 (es) |
| JP (1) | JP6474423B2 (es) |
| KR (1) | KR102482699B1 (es) |
| CN (1) | CN106132405B (es) |
| AU (1) | AU2015242374B2 (es) |
| BR (1) | BR112016022880B1 (es) |
| CA (1) | CA2944113C (es) |
| CL (1) | CL2016002499A1 (es) |
| CY (1) | CY1121235T1 (es) |
| DK (1) | DK3125876T3 (es) |
| EA (1) | EA032116B1 (es) |
| EC (1) | ECSP16078100A (es) |
| ES (1) | ES2659174T3 (es) |
| GB (1) | GB2524831A (es) |
| HR (1) | HRP20180325T1 (es) |
| HU (1) | HUE036206T2 (es) |
| IL (1) | IL248027B (es) |
| LT (1) | LT3125876T (es) |
| MA (1) | MA39833B1 (es) |
| ME (1) | ME03012B (es) |
| MX (1) | MX2016012591A (es) |
| NO (1) | NO3125876T3 (es) |
| NZ (1) | NZ724678A (es) |
| PE (1) | PE20170586A1 (es) |
| PH (1) | PH12016501975A1 (es) |
| PL (1) | PL3125876T3 (es) |
| PT (1) | PT3125876T (es) |
| RS (1) | RS56905B1 (es) |
| SA (1) | SA516371966B1 (es) |
| SG (1) | SG11201607478RA (es) |
| SI (1) | SI3125876T1 (es) |
| SM (1) | SMT201800116T1 (es) |
| UA (1) | UA119558C2 (es) |
| WO (1) | WO2015150793A1 (es) |
| ZA (1) | ZA201606406B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005057D0 (en) | 2020-04-06 | 2020-05-20 | Emeramed Ltd | New Use |
| CN114778234B (zh) * | 2022-03-18 | 2025-08-15 | 武汉新烽光电股份有限公司 | 一种用于微流控总磷测试的抗坏血酸溶液的保存方法及保存结构 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586600B2 (en) | 2000-12-06 | 2003-07-01 | University Of Kentucky Research Foundation | Multidentate sulfur-containing ligands |
| JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物 |
| US8950583B2 (en) * | 2008-12-06 | 2015-02-10 | Ermes Medical Company Limited | Method to remove heavy metals from a mammal |
| US8575218B2 (en) * | 2009-09-28 | 2013-11-05 | The University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| AU2010297933A1 (en) | 2009-09-28 | 2012-04-19 | University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| US8426368B2 (en) | 2010-03-25 | 2013-04-23 | The University Of Kentucky Research Foundation | Method of ameliorating oxidative stress and supplementing the diet |
| US20110237776A1 (en) | 2010-03-25 | 2011-09-29 | Haley Boyd E | Aromatic compounds with sulfur containing ligands |
-
2014
- 2014-04-04 GB GB1406115.4A patent/GB2524831A/en not_active Withdrawn
-
2015
- 2015-03-31 SG SG11201607478RA patent/SG11201607478RA/en unknown
- 2015-03-31 MX MX2016012591A patent/MX2016012591A/es active IP Right Grant
- 2015-03-31 UA UAA201611073A patent/UA119558C2/uk unknown
- 2015-03-31 ES ES15723546.6T patent/ES2659174T3/es active Active
- 2015-03-31 HR HRP20180325TT patent/HRP20180325T1/hr unknown
- 2015-03-31 PT PT157235466T patent/PT3125876T/pt unknown
- 2015-03-31 WO PCT/GB2015/050999 patent/WO2015150793A1/en not_active Ceased
- 2015-03-31 AU AU2015242374A patent/AU2015242374B2/en active Active
- 2015-03-31 PE PE2016001785A patent/PE20170586A1/es unknown
- 2015-03-31 US US15/129,654 patent/US9782368B2/en active Active
- 2015-03-31 ME MEP-2018-50A patent/ME03012B/me unknown
- 2015-03-31 HU HUE15723546A patent/HUE036206T2/hu unknown
- 2015-03-31 SI SI201530158T patent/SI3125876T1/en unknown
- 2015-03-31 NO NO15723546A patent/NO3125876T3/no unknown
- 2015-03-31 NZ NZ724678A patent/NZ724678A/en unknown
- 2015-03-31 EP EP15723546.6A patent/EP3125876B8/en active Active
- 2015-03-31 KR KR1020167030801A patent/KR102482699B1/ko active Active
- 2015-03-31 EA EA201692013A patent/EA032116B1/ru unknown
- 2015-03-31 SM SM20180116T patent/SMT201800116T1/it unknown
- 2015-03-31 BR BR112016022880-4A patent/BR112016022880B1/pt active IP Right Grant
- 2015-03-31 MA MA39833A patent/MA39833B1/fr unknown
- 2015-03-31 PL PL15723546T patent/PL3125876T3/pl unknown
- 2015-03-31 CA CA2944113A patent/CA2944113C/en active Active
- 2015-03-31 LT LTEP15723546.6T patent/LT3125876T/lt unknown
- 2015-03-31 CN CN201580017210.4A patent/CN106132405B/zh active Active
- 2015-03-31 RS RS20180210A patent/RS56905B1/sr unknown
- 2015-03-31 JP JP2016557313A patent/JP6474423B2/ja active Active
- 2015-03-31 DK DK15723546.6T patent/DK3125876T3/en active
-
2016
- 2016-09-16 ZA ZA2016/06406A patent/ZA201606406B/en unknown
- 2016-09-25 IL IL248027A patent/IL248027B/en active IP Right Grant
- 2016-09-30 CL CL2016002499A patent/CL2016002499A1/es unknown
- 2016-09-30 EC ECIEPI201678100A patent/ECSP16078100A/es unknown
- 2016-10-01 SA SA516371966A patent/SA516371966B1/ar unknown
- 2016-10-04 PH PH12016501975A patent/PH12016501975A1/en unknown
-
2018
- 2018-02-09 CY CY20181100160T patent/CY1121235T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301212I2 (nl) | Lenacapavir of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder lenacapavir natrium | |
| ECSP20025899A (es) | Compuestos útiles para inhibir a cdk7 | |
| MX2019009443A (es) | Metodos para tratar la influenza. | |
| MX2017006224A (es) | Derivados heterociclicos y usos de los mismos. | |
| SV2015005115A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
| MX2017003819A (es) | Macrociclos peptidomimeticos y formulaciones de los mismos. | |
| IL249837B (en) | Inhaler for pulmonary delivery of active agents | |
| BR112015002524A2 (pt) | derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças. | |
| LT3206716T (lt) | Kanabinoidų panaudojimas atoninių traukulių gydymui, esant lennox-gastaut' sindromui | |
| LT2945642T (lt) | Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai | |
| MX383499B (es) | Agentes terapeuticos para enfermedades neurodegenerativas | |
| PL3556377T3 (pl) | Dalargin do stosowania w leczeniu ostrych infekcji wirusowych dróg oddechowych | |
| CL2017000050A1 (es) | Terapia de combinación para el cáncer | |
| CL2016002940A1 (es) | Derivado de carotenoides, sal farmacéuticamente aceptable del mismo, o éster o amida farmacéuticamente aceptables del mismo | |
| AR112144A1 (es) | Compuestos para el tratamiento del sarcoma | |
| LT3436074T (lt) | Tiazolido junginiai, skirti virusinių infekcijų gydymui | |
| LT3687567T (lt) | Anti-adrenomedulino rišiklis, skirtas panaudoti taikant ligos simptomų terapiją arba profilaktiką | |
| LT3261642T (lt) | Chinolino dariniai, skirti naudoti virusinės infekcijos gydymui arba prevencijai | |
| LT3153511T (lt) | 2-acilaminotiazolo dariniai, skirti panaudoti šlapimo pūslės/šlapimo takų ligų prevencijai arba gydymui | |
| LT3113778T (lt) | Piridazino dariniai, skirti naudoti ataksinio sutrikimo profilaktikai arba gydymui | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
| MX388461B (es) | Acetil-leucina o una sal farmacéuticamente aceptable de la misma para mejorar la movilidad y función cognitiva. | |
| MX2017012926A (es) | Inhibidores y sus usos. | |
| ECSP16078100A (es) | Nuevo uso de n,n -2-bis- mercaptoetil isoftalamida | |
| UY36732A (es) | Piridin pirazinonas novedosas como inhibidores de bromodominios de la familia bet |